Friedelin: Structure, Biosynthesis, Extraction, and Its Potential Health Impact

Area of Science:

• Phytochemistry
• Pharmacology
• Biotechnology

Background:

• Friedelin (friedelan-3-one) is a pentacyclic triterpene found in diverse plant species, mosses, and lichens.
• It is abundant in cork tissues and leaf materials of genera like Celastraceae, Asteraceae, Fabaceae, and Myrtaceae.
• Friedelin exhibits various pharmacological activities, including anti-inflammatory, antioxidant, anticancer, and antimicrobial effects, and agricultural benefits.

Purpose of the Study:

• To review the structural interpretation, biosynthesis, and physicochemical properties of friedelin.
• To summarize the quantification methods and diverse pharmacological significance of friedelin.
• To highlight recent advancements in friedelin production and its potential as a pharmaceutical agent.

Main Methods:

• Extraction of friedelin using environmentally friendly techniques such as ultrasound, microwave, supercritical fluid, ionic liquid, and acid hydrolysis.
• Production of friedelin via genetically engineered yeast using CRISPR/Cas9 technology and gene overexpression plasmids.
• Analysis of structural interpretation, biosynthesis, physicochemical properties, and quantification.

Main Results:

• Friedelin possesses a wide range of pharmacological effects, including anti-inflammatory, antioxidant, anticancer, and antimicrobial activities.
• It demonstrates agricultural utility through its anti-insect effect and ability to modify soil microbial ecology.
• Engineered yeast systems offer a promising avenue for scalable friedelin production with low cytotoxicity.

Conclusions:

• Friedelin is a valuable phytochemical with significant therapeutic and agricultural potential.
• Advanced biotechnological approaches are crucial for meeting the growing demand for friedelin.
• Its low cytotoxicity makes friedelin a strong candidate for drug development.